Bill > A02145

This bill amends the New York State Education Law to allow prescription labels for specific medications used in reproductive healthcare - mifepristone and misoprostol (and their generic alternatives) - to include the name of the healthcare practice instead of the individual prescriber's name, when the prescriber requests this option. Mifepristone and misoprostol are medications commonly used for medical abortion and managing certain gynecological conditions. Currently, prescription labels typically require the specific prescriber's name, but this bill would provide flexibility for healthcare practices to use their institutional name on the label, which could help protect individual providers' privacy and potentially reduce potential harassment or stigma. The changes apply to both the dispensing and prescribing aspects of these medication labels, and the bill would take effect immediately upon passage. This modification represents a small but potentially meaningful adjustment to prescription labeling practices for sensitive medical treatments.

Education

https://www.nysenate.gov/legislation/bills/2025/A2145